Search Results 1091-1100 of 16995 for Cosmeceutical
Mayo Clinic's Center for Individualized Medicine is set to host its 13th Annual Individualizing Medicine Conference on Sept. 11-12 in Rochester, Minnesota.
The Department of Molecular Pharmacology and Experimental Therapeutics at Mayo Clinic has multiple laboratories exploring a range of research focus areas.
This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...
Latest stories · Science Saturday: How disease, diet, and genomics interact with gut virome featured image · Researchers review how sex steroids change gut, ...
Imiquimod may stimulate the immune system. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.
Latest stories · Mayo Clinic scientists define new type of memory loss in older adults featured image · Mayo Clinic Minute: Treatment and research of glioblastoma ...
Black History Month: Honoring Dr. · Mayo Clinic Cancer Center researchers identify promising drug to treat gastrointestinal cancers featured image · Expert Alert: ...
Mayo Clinic accelerates personalized medicine through foundation models with Microsoft Research and Cerebras Systems featured image · 8 common health conditions ...
This year's National Resident Matching Program brought nearly 350 new residents to Mayo Clinic campuses, where they began three- to seven-year commitments.
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.